Cipla Limited has entered into definitive agreements to invest in Optionally Convertible Preference Shares of iCaltech Innovations Private Limited. The investment is subject to the fulfilment of certain conditions.
iCaltech’s Focus on Respiratory Care Innovation
iCaltech Innovations designs, develops, and commercialises diagnostic medical equipment. The company has a strong focus on respiratory care solutions. The company’s innovative approach aligns with Cipla’s mission to enhance healthcare accessibility through cutting-edge technology.
Strengthening Lung Leadership through Strategic Funding
Commenting on the move, Mr. Achin Gupta, Global COO of Cipla Limited, stated, “As lung leaders, our decision to invest in iCaltech reflects Cipla’s commitment to advancing respiratory diagnostics. With the aim to reduce the existing gap in the current ecosystem, our strategic funding will enable iCaltech to further expand and develop innovative devices. We remain committed towards providing easy access to high-quality diagnostic solutions across India.”
Expanding the Devices and Diagnostics Portfolio
As per Cipla press release, this investment reinforces Cipla’s broader strategy of forming strategic partnerships to fuel its innovation engine. The company continues to strengthen its presence across digital, devices, and diagnostics segments. It builds on its long-standing leadership in the respiratory domain.
Conclusion
With this investment, Cipla aims to drive meaningful change in respiratory diagnostics, fostering innovation and improving patient access to advanced healthcare technologies across India.